16 https://www.efsa.europa.eu ORG-0001 European Food Safety Authority Via Carlo Magno 1A EFSA.ED - Executive Director,EFSA.ED.CSO - Chief Scientist Office Parma I-43126 ITH52 ITA EFSA +39 0521 036 111 efsaprocurement@efsa.europa.eu http://curia.europa.eu ORG-0002 Court of Justice of the European Union Rue du Fort Niedergrünewald Luxembourg L-2925 LU000 LUX CURIA +352 4303-1 GC.Registry@curia.europa.eu https://commission.europa.eu/ ORG-0003 European Commission Mondrian (CDMA), Rue du Champ de Mars 21 Brussels B-1050 BE100 BEL EUCOM +32 2 299 11 11 efsaprocurement@efsa.europa.eu 00265234-202675/20262026-04-17+02:00 2.3 eforms-sdk-1.14 6bdd84d2-7c8c-48b8-96d8-ee859d89171b 117980b2-c96a-48dc-af0f-9fcedb49d1b3 2026-04-16+02:00 11:26:57+02:00 01 32024R2509 cn-standard ENG eu-ins-bod-ag gen-pub ORG-0001 ted-esen ORG-0003 epo-procurement-document For the full list of exclusion grounds please consult the procurement documents. open false EFSA/2026/OP/0010 Novel strategy for allergenicity risk assessment of proteins in regulated food and feed products The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed. For both clinically-relevant cross-reactivity and de novo sensitisation, the project foresees the development of open source in silico prediction/appraisal tools to be validated with experimental data; assessment of future prospects for in silico tools; estimation of thresholds of allergological concern, and the development of a systematic tiered approach with a decision-making framework. This novel strategy will enhance the reliability and speed of allergenicity RA and support process simplification and harmonisation, ultimately enabling better-informed risk management decision-making.  services In case of unavailability or disruptions in the functioning of the electronic means of communication provided in Section 5.1.11 in the last 5 calendar days before the time limit for receipt indicated in Section 5.1.12, the contracting authority reserves the right to extend this time limit and publish the extension at the Internet address provided in Section 5.1.11, without a preceding publication of a corrigendum to this notice. Economic operators interested in this procurement are invited to subscribe to the call for tenders at the address in Section 5.1.11 in order to get notified when new information or documents are published. true 1300000 73000000 Please consult the procurement documents. anyw-eea LOT-0001 eu-funds default-text non-restricted-document ENG official https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/117980b2-c96a-48dc-af0f-9fcedb49d1b3-CN?#anchorDocuments epo-procurement-document none no allowed not-allowed per-exa 70 quality Please consult the procurement documents. per-exa 30 price Please consult the procurement documents. https://webgate.ec.europa.eu/digit/opsys/esubmission?cftUuid=117980b2-c96a-48dc-af0f-9fcedb49d1b3 9 ORG-0001 ORG-0002 BUL CES DAN DEU ELL ENG SPA EST FIN FRA GLE HRV HUN ITA LIT LAV MLT NLD POL POR RON SLK SLV SWE true true Funding and Tenders Portal required false https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/tender-details/117980b2-c96a-48dc-af0f-9fcedb49d1b3-CN?#anchorDocuments 2026-06-23+02:00 14:30:59+02:00 2026-06-15+02:00 23:59:59+02:00 106237-2026 2026-06-24+02:00 14:30:00+02:00 false 1 fa-wo-rc none EFSA/2026/OP/0010 Novel strategy for allergenicity risk assessment of proteins in regulated food and feed products The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed. For both clinically-relevant cross-reactivity and de novo sensitisation, the project foresees the development of open source in silico prediction/appraisal tools to be validated with experimental data; assessment of future prospects for in silico tools; estimation of thresholds of allergological concern, and the development of a systematic tiered approach with a decision-making framework. This novel strategy will enhance the reliability and speed of allergenicity RA and support process simplification and harmonisation, ultimately enabling better-informed risk management decision-making.  services 1300000 73000000 Please consult the procurement documents. anyw-eea 48 provided they are in conformity with the basic project, new services or works consisting in the repetition of similar services or works, may be entrusted up to 50 % of the initial contract to the initial contractor by negotiated procedure without prior publication of a contract notice. 3 The framework contract is concluded for an initial period of 12 (twelve) months, renewable 3 (three) time(s). Please consult the draft framework contract in the procurement documents.